Ambrx Biopharma Inc - ADR Stock, NYSE:AMAM
10975 North Torrey Pines Road, La Jolla, California 92037
United States of America
Number of Employees: 70
Ambrx Biopharma Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.